Ignite Creation Date:
2025-12-24 @ 2:32 PM
Ignite Modification Date:
2026-01-07 @ 3:29 AM
Study NCT ID:
NCT05082259
Status:
RECRUITING
Last Update Posted:
2025-05-20
First Post:
2021-10-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab
Sponsor:
Institute of Cancer Research, United Kingdom
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2026-03-16
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-03-16
Completion Date Type:
ESTIMATED
First Submit Date:
2021-10-06
First Submit QC Date:
None
Study First Post Date:
2021-10-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-15
Last Update Post Date:
2025-05-20
Last Update Post Date Type:
ACTUAL